PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review)

  • Miricescu D
  • Balan D
  • Tulin A
  • et al.
N/ACitations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Renal cell carcinoma (RCC) accounts for over 90% of all renal malignancies, and mainly affects the male population. Obesity and smoking are involved in the pathogenesis of several systemic cancers including RCC. The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signalling pathway regulates cell growth, differentiation, migration, survival, angiogenesis, and metabolism. Growth

Cite

CITATION STYLE

APA

Miricescu, D., Balan, D., Tulin, A., Stiru, O., Vacaroiu, I., Mihai, D., … Stefani, C. (2021). PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review). Experimental and Therapeutic Medicine, 21(5). https://doi.org/10.3892/etm.2021.9972

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free